Notably, melanoma-associated antigen-A11 (MAGE-A11)-specific CTLs, when combined with a Tim-3 and PD-1 blockade, demonstrated significantly amplified cytotoxic effects against breast cancer cells [41]. Here, PDCD1 is linked to breast cancer.